J7685 – Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7685
- Long description
- Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
- Short description
- Tobramycin comp unit
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
D1GDrugs Administered through DME- Added
- January 1, 2007
- Last change
- January 1, 2007 – No change
Frequently asked questions
What is HCPCS code J7685?
J7685 is a HCPCS Level II code for tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams.
Does Medicare cover J7685?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7674 – Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
- J7676 – Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
- J7677 – Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
- J7680 – Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7681 – Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7682 – Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- J7683 – Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7684 – Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7686 – Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
- J7699 – Noc drugs, inhalation solution administered through dme
- J7799 – Noc drugs, other than inhalation drugs, administered through dme
- J7999 – Compounded drug, not otherwise classified
- J8498 – Antiemetic drug, rectal/suppository, not otherwise specified
- J8499 – Prescription drug, oral, non chemotherapeutic, nos
- J8501 – Aprepitant, oral, 5 mg
- J8502 – Injection, aprepitant (aponvie), 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.